Skip to main content
Premium Trial:

Request an Annual Quote

Bio-Rad Laboratories Sees Q3 Sales Rise 4 Percent

NEW YORK (GenomeWeb News) – Bio-Rad Laboratories reported after the market closed on Tuesday that its third-quarter revenues rose 4 percent driven by strong clinical diagnostics sales.

The firm reported total revenues of $461.1 million for the three-month period ended Sept. 30, compared to revenues of $441.8 million for the third quarter of 2008. On a currency-neutral basis, Bio-Rad's revenue growth for the quarter was 11 percent.

It beat analysts' consensus estimate on both the top and bottom line.

Bio-Rad said that its life science products business generated revenues of $150.4 million, a drop of around 4 percent year over year, or less than 1 percent on a currency-neutral basis. Sales of the firm's clinical diagnostic products were $307.5 million, up around 9 percent compared to the period a year ago.

Bio-Rad said that the year-over-year decline in the life science business was impacted by slowed research markets in the US and in Europe.

"As we had expected, the economy continued to have somewhat of a negative impact on customer spending particularly in our Life Science segment, but we are encouraged by the resiliency we've seen in many of our markets," Bio-Rad President and CEO Norman Schwartz said in a statement.

The firm posted a profit of $38.5 million, or $1.38 per share, up from $27.8 million, or $1.00 per share, for the third quarter of 2008.

The company's R&D costs rose 2 percent over the year before to $39.5 million, compared to $38.8 million, while its SG&A spending ticked up to $153.6 million from $150.5 million.

Bio-Rad finished the quarter with $554.2 million in cash and cash equivalents and $87.9 million in short-term investments.

In early Wednesday trade on the New York Stock Exchange, shares of Bio-Rad were up 4 percent at $94.38.

The Scan

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.

Study Highlights Pitfall of Large Gene Panels in Clinical Genomic Analysis

An analysis in Genetics in Medicine finds that as gene panels get larger, there is an increased chance of uncovering benign candidate variants.

Single-Cell Atlas of Drosophila Embryogenesis

A new paper in Science presents a single-cell atlas of fruit fly embryonic development over time.

Phage Cocktail Holds Promise for IBD

Researchers uncovered a combination phage therapy that targets Klebsiella pneumonia strains among individuals experiencing inflammatory bowel disease flare ups, as they report in Cell.